FDA understands that when a drug is in shortage, patients and health care professionals may look to compounded drugs as an option to get their medication.| U.S. Food and Drug Administration
FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize| U.S. Food and Drug Administration
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss| U.S. Food and Drug Administration